Andrew T Magis
Overview
Explore the profile of Andrew T Magis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
2704
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xie J, Chen D, Chour W, Ng R, Zhang R, Yuan D, et al.
Nat Commun
. 2025 Feb;
16(1):1402.
PMID: 39915487
Elucidating the relationships between a class I peptide antigen, a CD8 T cell receptor (TCR) specific to that antigen, and the T cell phenotype that emerges following antigen stimulation, remains...
2.
Xie J, Chen D, Chour W, Ng R, Zhang R, Yuan D, et al.
bioRxiv
. 2025 Jan;
PMID: 39829843
Elucidating the relationships between a class I peptide antigen, a CD8 T cell receptor (TCR) specific to that antigen, and the T cell phenotype that emerges following antigen stimulation, remains...
3.
Ellis D, Watanabe K, Wilmanski T, Lustgarten M, Ardisson Korat A, Glusman G, et al.
bioRxiv
. 2024 Nov;
PMID: 39605362
Apolipoprotein E ( ) modifies human aging; specifically, the ε2 and ε4 alleles are among the strongest genetic predictors of longevity and Alzheimer's disease (AD) risk, respectively. However, detailed mechanisms...
4.
Kornilov S, Price N, Gelinas R, Acosta J, Brunkow M, Gervasi-Follmar T, et al.
J Neurol Sci
. 2024 Nov;
467:123303.
PMID: 39561535
The study examined changes in the plasma proteome, metabolome, and lipidome of N = 14 patients with relapsing-remitting multiple sclerosis (RRMS) initiating treatment with ocrelizumab, assayed at baseline, 6 months,...
5.
Johnson-Martinez J, Diener C, Levine A, Wilmanski T, Suskind D, Ralevski A, et al.
Cell Rep Med
. 2024 Jul;
5(7):101646.
PMID: 39019013
Bowel movement frequency (BMF) directly impacts the gut microbiota and is linked to diseases like chronic kidney disease or dementia. In particular, prior work has shown that constipation is associated...
6.
Johnson-Martinez J, Diener C, Levine A, Wilmanski T, Suskind D, Ralevski A, et al.
bioRxiv
. 2023 Mar;
PMID: 36945445
Bowel movement frequency (BMF) has been linked to changes in the composition of the human gut microbiome and to many chronic conditions, like metabolic disorders, neurodegenerative diseases, chronic kidney disease...
7.
Watanabe K, Wilmanski T, Diener C, Earls J, Zimmer A, Lincoln B, et al.
Nat Med
. 2023 Mar;
29(4):996-1008.
PMID: 36941332
Multiomic profiling can reveal population heterogeneity for both health and disease states. Obesity drives a myriad of metabolic perturbations and is a risk factor for multiple chronic diseases. Here we...
8.
Diener C, Dai C, Wilmanski T, Baloni P, Smith B, Rappaport N, et al.
Nat Metab
. 2022 Nov;
4(11):1560-1572.
PMID: 36357685
Variation in the blood metabolome is intimately related to human health. However, few details are known about the interplay between genetics and the microbiome in explaining this variation on a...
9.
Wilmanski T, Kornilov S, Diener C, Conomos M, Lovejoy J, Sebastiani P, et al.
Med
. 2022 Jun;
3(6):388-405.e6.
PMID: 35690059
Background: Statins remain one of the most prescribed medications worldwide. While effective in decreasing atherosclerotic cardiovascular disease risk, statin use is associated with adverse effects for a subset of patients,...
10.
Omenn G, Magis A, Price N, Hood L
Methods Mol Biol
. 2022 Apr;
2486:315-334.
PMID: 35437729
The dramatic convergence of molecular biology, genomics, proteomics, metabolomics, bioinformatics, and artificial intelligence has provided a substrate for deep understanding of the biological basis of health and disease. Systems biology...